Prev Arrow Stocks

Tilray Inc. ($TLRY) Stock Forecast: Up 6.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Tilray Inc.?

Tilray Brands (NASDAQ: TLRY) is a prominent cannabis company recognized for its global operations and key partnerships. The stock saw a significant uptrend today following its strong third-quarter financial results.

Why is Tilray Inc. going up?

TLRY stock is up 6.5% on Apr 2, 2026 18:01

  • Strong Q3 earnings and a surge in international cannabis revenue contributed to Tilray exceeding revenue expectations, prompting a positive market response.
  • Analysts raised their rating on Tilray to Buy, setting a price target of $10, and expressed optimism about the company's future growth potential.
  • Despite the favorable earnings, concerns over varying margin trends, uncertainty in EPS reporting, and analyst downgrades caused a brief 5.1% decrease in the stock price after the earnings release, revealing the difficulties in maintaining consistent profitability amid revenue growth.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Stock Continues To Climb After Earnings Beat, Record Revenue

Tilray Brands (NASDAQ: TLRY) reported stronger-than-expected earnings and record revenue for its fiscal third quarter, sending its stock higher. The company beat analyst estimates with adjusted earnings of 2 cents per share and revenue of $206.7 million, driven by significant growth in international cannabis revenue. Roth Capital also upgraded Tilray to Buy with a $10 price target, further contributing to the bullish sentiment.

https://www.benzinga.com/trading-ideas/movers/26/04/51631571/tilray-stock-continues-to-climb-after-earnings-beat-record-revenue

0 News Article Image Tilray Stock Continues To Climb After Earnings Beat, Record Revenue

Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish

Jefferies analysts maintained a 'Buy' rating for Tilray Brands (NASDAQ:TLRY) and reiterated a $24 price target after the company reported strong third-quarter earnings. Tilray's revenue growth, driven by a 19% increase in cannabis sales, exceeded expectations, with international cannabis operations being a key outperformer. Despite softness in craft beer sales, the company reaffirmed its fiscal 2026 adjusted EBITDA guidance, signaling confidence in future margin expansion and growth from strategic partnerships.

https://www.proactiveinvestors.com/companies/news/1090031/tilray-brands-strong-cannabis-sales-and-upbeat-outlook-keeps-jefferies-analysts-bullish-1090031.html

1 News Article Image Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish

Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?

Tilray Brands reported mixed fiscal Q3 2026 earnings, with revenues exceeding estimates but earnings missing. The company's diversified model, including distribution and international cannabis, is driving growth, despite pressures in the beverage segment. While competition remains intense, Tilray maintains a "Hold" Zacks Rank, suggesting a wait-and-see approach for investors.

https://www.tradingview.com/news/zacks:9f8767165094b:0-should-tilray-brands-be-in-your-portfolio-post-q3-earnings/

2 News Article Image Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?

Tudor Investment Corp ET AL Purchases New Position in Tilray Brands, Inc. $TLRY

Tudor Investment Corp ET AL has initiated a new position in Tilray Brands, Inc. by purchasing 299,398 shares valued at approximately $518,000, contributing to a total institutional ownership of 9.35%. Despite Tilray reporting a record quarter with revenue and EPS beats and strong international cannabis growth, the company remains unprofitable, leading to analyst downgrades and a negative market reaction. Analysts currently rate Tilray as a Hold with an average price target of $11.75.

https://www.marketbeat.com/instant-alerts/filing-tudor-investment-corp-et-al-purchases-new-position-in-tilray-brands-inc-tlry-2026-04-02/

3 News Article Image Tudor Investment Corp ET AL Purchases New Position in Tilray Brands, Inc. $TLRY

Tilray Brands (NASDAQ:TLRY) Trading Down 5.1% - Here's Why

Tilray Brands (NASDAQ:TLRY) shares fell 5.1% on heavy volume following its Q3 earnings report, despite record revenue of approximately $206–207 million. The decline was attributed to investor concerns over mixed margin trends, confusion regarding EPS reporting, and analyst downgrades. Although the company saw a 73% increase in international cannabis revenue and expanded its beverage business, challenges in translating top-line growth into consistent profit improvements led to selling pressure.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-trading-down-51-heres-why-2026-04-01/

4 News Article Image Tilray Brands (NASDAQ:TLRY) Trading Down 5.1% - Here's Why

Tilray Inc. Price History

02.03.2026 - TLRY Stock was up 6.5%

  • Strong Q3 earnings and a surge in international cannabis revenue contributed to Tilray exceeding revenue expectations, prompting a positive market response.
  • Analysts raised their rating on Tilray to Buy, setting a price target of $10, and expressed optimism about the company's future growth potential.
  • Despite the favorable earnings, concerns over varying margin trends, uncertainty in EPS reporting, and analyst downgrades caused a brief 5.1% decrease in the stock price after the earnings release, revealing the difficulties in maintaining consistent profitability amid revenue growth.

02.03.2026 - TLRY Stock was up 5.4%

  • Despite achieving record Q3 revenue of $206.7 million, Tilray's stock declined by 5.1% due to concerns about mixed margin trends, confusion around EPS reporting, and analyst downgrades.
  • The company's efforts in international cannabis revenue growth and strategic acquisitions were somewhat overshadowed by difficulties in converting top-line growth into consistent profit enhancements.
  • Investors have reservations concerning a notable adjusted EPS shortfall, ongoing shareholder dilution, and slow advancements in U.S. cannabis rescheduling, which have influenced market perceptions despite the positive revenue outcome.
  • Tilray's stock performance fell short of market expectations, closing well below its 52-week high, reflecting investor sentiment towards the company's financial performance and growth strategies.

10.02.2026 - TLRY Stock was up 6.9%

  • TLRY's bullish movement can be attributed to its strategic acquisition of BrewDog's Australian assets, including the Brisbane brewery and a network of bars, to expand its presence in the Asia-Pacific region.
  • The expansion into Australia serves as a gateway for Tilray to introduce its broader beverage portfolio to new markets, enhancing its global beverage revenues.
  • This move not only strengthens Tilray's international brewing footprint but also positions the company to capitalize on the growing demand for craft beverages in the Asia-Pacific market, driving investor optimism and contributing to the bullish market movement of TLRY.

01.03.2026 - TLRY Stock was down 5.1%

  • Despite reporting record Q3 revenue of $206.7 million, Tilray's stock experienced a bearish movement due to concerns over a significant adjusted EPS miss, continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling.
  • The surge in international cannabis sales by 73% sparked a rally in Tilray's shares, but the narrowed net loss that still missed consensus might have contributed to the overall bearish sentiment.
  • Anticipation of strong Q3 earnings, a new product launch, and decreased short interest led to a premarket surge in Tilray's stock, indicating short-term gains amidst a longer-term downtrend.
  • Investors are eagerly waiting for revenue growth to translate into sustainable profitability for Tilray, as the company navigates through challenges and opportunities in the cannabis market.

20.02.2026 - TLRY Stock was down 5.4%

  • Acquired BrewDog's US assets to expand alcohol beverage portfolio did not have a positive impact on stock price.
  • Despite expanding medical cannabis portfolio in Australia, introducing new products did not prevent bearish trend.
  • Underperformance compared to broader market and sector, along with anticipation of negative earnings per share in upcoming report, likely led to bearish movement.
  • Consecutive days of losses amidst challenging trading session for overall market emphasized bearish sentiment surrounding the stock.

30.02.2026 - TLRY Stock was down 5.2%

  • Despite beating quarterly EPS and revenue estimates, Tilray's stock saw a significant dip, possibly due to concerns about the company's profitability and negative EPS forecasts for the current year.
  • The lawsuit filed by Bob Marley's heirs against Tilray for unpaid licensing fees may have added to investor uncertainty and contributed to the bearish movement of the stock.
  • The partnership announcement with Popsicle to launch new alcoholic beverages could have been overshadowed by the negative market sentiment, failing to provide a positive impact on the stock price.
  • Analysts' adjustments to price targets and earnings estimates, along with the overall market downturn, likely influenced investors to sell off Tilray shares, leading to the underperformance of the stock.

26.02.2026 - TLRY Stock was down 5.2%

  • Concerns arose among investors due to Tilray's partnership with Popsicle to launch "Popsicle Hard" beverages, potentially affecting its core business focus.
  • The anticipation of Tilray's third-quarter fiscal year 2026 financial results on April 1, 2026, could be causing uncertainty and volatility in the stock.
  • Investor caution regarding the financial results may lead to a sell-off of Tilray stock in expectation of disappointing earnings or guidance.
  • The absence of specific positive updates or catalysts may be contributing to the bearish sentiment surrounding Tilray's stock today.

25.02.2026 - TLRY Stock was up 6.6%

  • The increase in Tilray's stock price is likely the result of oversold conditions, leading to short-term optimism among investors.
  • Anticipation for the upcoming third fiscal quarter results scheduled for April 1, 2026, has contributed to positive market sentiment.
  • Despite facing profitability challenges with a negative net margin, recent company activities such as acquiring BrewDog U.S. assets and expanding medical cannabis partnerships have bolstered investor confidence.
  • Analyst opinions on the stock vary, with a consensus "Hold" rating; however, the temporary rebound suggests that investors are cautiously positive about Tilray's future prospects.

25.02.2026 - TLRY Stock was up 8.2%

  • TLRY stock rose by 3.57% to $6.68 today, following recent bearish trends, despite trading below significant moving averages.
  • The stock's uptick may be linked to oversold conditions identified by certain technical indicators, attracting short-term investors seeking opportunities.
  • Uncertainty over U.S. federal cannabis rescheduling discussions continues to impact investor sentiment, contributing to the stock's volatility.
  • TLRY's recent acquisition of craft brewer BrewDog and CEO Irwin Simon's plans to revitalize the brand through expansion efforts may have also influenced the positive market movement, highlighting the company's commitment to diversification and growth strategies.

05.02.2026 - TLRY Stock was down 5.2%

  • The purchase of BrewDog brand and assets may have sparked initial investor interest, but the subsequent stock decline suggests concerns over deal execution or financial impacts.
  • Despite expansions in product lines and partnerships, overall market sentiment and uncertainties about the upcoming earnings report likely contributed to TLRY's bearish movement.
  • Good Supply's introduction of high-THC products could have provided a small boost, but the limited availability and regional exclusivity may not have been enough to counter broader market pressures.
  • TLRY's stock outperformance in the last month despite sector challenges highlights investor scrutiny, particularly with the upcoming earnings report shaping market sentiments.

27.02.2026 - TLRY Stock was down 5.0%

  • Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
  • The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
  • The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
  • Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

31.02.2026 - TLRY Stock was up 5.3%

  • The launch of Shock Top's "High Voltage" beer with bold orange flavors and a 9.6% ABV has created market buzz. However, investor focus appears to be more on the company's financial standing.
  • Despite Tilray surpassing quarterly estimates, analysts have downgraded the stock to a "Hold" and reduced price targets, indicating concerns about profitability and financial well-being.
  • The forthcoming earnings report on April 1st will be a key factor in shaping the stock's future direction, with investors eager to see if Tilray's financial performance shows any signs of recovery.
  • Despite prevailing pessimism, the rise in institutional investors' holdings in the cannabis firm suggests enduring confidence in Tilray's growth prospects, potentially offering some stability to the stock in the short term.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.